87 related articles for article (PubMed ID: 12075620)
1. From the Centers for Disease Control and Prevention. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
JAMA; 2002 Jun; 287(23):3071-3. PubMed ID: 12075620
[No Abstract] [Full Text] [Related]
2. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 May; 51(18):392-4. PubMed ID: 12018795
[TBL] [Abstract][Full Text] [Related]
3. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009).
Jones RN; Sader HS; Moet GJ; Farrell DJ
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):334-6. PubMed ID: 20955919
[No Abstract] [Full Text] [Related]
4. [Healthy young adult carriers of Streptococcus pneumoniae and antibiotic susceptibility].
Urquía Grande ML; Maestre Vera JR; Prieto Prieto J
Rev Esp Quimioter; 2005 Sep; 18(3):245-6. PubMed ID: 16369669
[No Abstract] [Full Text] [Related]
5. Effect of new breakpoints proposed by Clinical and Laboratory Standards Institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital.
Doğan O; Gülmez D; Hasçelik G
Microb Drug Resist; 2010 Mar; 16(1):39-41. PubMed ID: 19916790
[TBL] [Abstract][Full Text] [Related]
6. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
Jones RN; Sader HS; Mendes RE; Flamm RK
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):107-9. PubMed ID: 23009730
[TBL] [Abstract][Full Text] [Related]
7. First reporting of the penicillin susceptibility of invasive Streptococcus pneumoniae isolates from the Northern Territory of Australia.
Brischetto A; Baird R; Hennessy J
Int J Antimicrob Agents; 2014 Sep; 44(3):278-9. PubMed ID: 25108875
[No Abstract] [Full Text] [Related]
8. Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality.
Yu VL; Baddour LM
Clin Infect Dis; 2004 Oct; 39(7):1086-7; author reply 1087-8. PubMed ID: 15472872
[No Abstract] [Full Text] [Related]
9. Emergence of drug-resistant pneumococcal infections in the United States.
Breiman RF; Butler JC; Tenover FC; Elliott JA; Facklam RR
JAMA; 1994 Jun; 271(23):1831-5. PubMed ID: 8196139
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.
Reinert RR; Simic S; Al-Lahham A; Reinert S; Lemperle M; Lütticken R
J Clin Microbiol; 2001 Mar; 39(3):1187-9. PubMed ID: 11230456
[TBL] [Abstract][Full Text] [Related]
11. Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001).
Oteo J; Campos J; Cruchaga S; Baquero G; Lázaro E; Madurga M; de Abajo FJ; Baquero F;
Clin Microbiol Infect; 2004 Sep; 10(9):851-4. PubMed ID: 15355420
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
13. Emergence of optochin resistance among Streptococcus pneumoniae in Portugal.
Aguiar SI; Frias MJ; Santos L; Melo-Cristino J; Ramirez M;
Microb Drug Resist; 2006; 12(4):239-45. PubMed ID: 17227208
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L.
Rodríguez-Cerrato V; Gracia M; Del Prado G; Huelves L; Naves P; Ruiz V; Ponte C; Soriano F
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):336-8. PubMed ID: 19939599
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant pneumococcal infections in the United States. A problem for clinicians, laboratories, and public health.
Simberkoff MS
JAMA; 1994 Jun; 271(23):1875-6. PubMed ID: 8196147
[No Abstract] [Full Text] [Related]
16. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
[TBL] [Abstract][Full Text] [Related]
17. [The antibiotic resistance and serotypes of invasive Streptococcus pneumoniae strains isolated in Italy].
Pantosti A
Ann Ig; 1999; 11(4):265-70. PubMed ID: 10520518
[No Abstract] [Full Text] [Related]
18. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
Maraki S; Mantadakis E; Samonis G
Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
[TBL] [Abstract][Full Text] [Related]
19. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.
Pletz MW; McGee L; Jorgensen J; Beall B; Facklam RR; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2004 Sep; 48(9):3491-7. PubMed ID: 15328116
[TBL] [Abstract][Full Text] [Related]
20. Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation.
Sader H; Del'Alamo L
Braz J Infect Dis; 2000 Oct; 4(5):268-70. PubMed ID: 11063559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
